Go Pro
OTCMKTS:BFNH

BioForce Nanosciences (BFNH) Stock Price, News & Analysis

BioForce Nanosciences logo
$1.65 0.00 (0.00%)
As of 06/26/2026

About BioForce Nanosciences Stock (OTCMKTS:BFNH)

Advanced

Key Stats

Today's Range
$1.65
$1.65
50-Day Range
$0.35
$1.79
52-Week Range
$0.18
$1.90
Volume
51 shs
Average Volume
10,619 shs
Market Capitalization
$55.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BFNH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioForce Nanosciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BFNH Stock News Headlines

BioForce Nanosciences Delays Annual 10-K Filing
The startup growing 23 times faster than Nvidia
An official SEC document contains a name Elon Musk revealed on page 146 - a startup that one analyst believes could be the next monster IPO on Wall Street. This company is growing 23 times faster than Nvidia. The Atlantic called it 'the fastest-growing business in the history of capitalism.' It has nothing to do with robots, self-driving cars, or rockets.tc pixel
BioForce Nanosciences Holdings, Inc. (BFNH)
BioForce Nanosciences Holdings Inc (BFNH)
See More Headlines

BFNH Stock Analysis - Frequently Asked Questions

BioForce Nanosciences' stock was trading at $0.5780 at the beginning of the year. Since then, BFNH stock has increased by 185.5% and is now trading at $1.65.

BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH) posted its quarterly earnings results on Tuesday, May, 13th. The company reported ($0.03) earnings per share for the quarter.

Shares of BFNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioForce Nanosciences investors own include Charlotte's Web (CWBHF).

Company Calendar

Last Earnings
5/13/2025
Today
6/30/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Measuring And Control Equipment
Current Symbol
OTCMKTS:BFNH
CIK
1310488
Employees
2
Year Founded
2003

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.29 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-20,856.95%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.01
Quick Ratio
0.01

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.02) per share
Price / Book
-82.50

Miscellaneous

Outstanding Shares
33,550,000
Free Float
20,284,000
Market Cap
$55.36 million
Optionable
Not Optionable
Beta
-0.31

Social Links

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (OTCMKTS:BFNH) was last updated on 6/30/2026 by MarketBeat.com Staff.
From Our Partners